한글목차

개 백신 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 38억 달러에서 2026년에는 40억 7,000만 달러로, CAGR 7.2%로 확대가 전망됩니다. 지난 수년간의 성장 요인으로는 전 세계 반려견 사육두수 증가, 반려견 질병에 대한 인식 개선, 신규 백신 유형 도입, 수의학 인프라 확충, 전염성 반려견 질병 확산 등을 꼽을 수 있습니다.

개 백신 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 CAGR 7.5%로 54억 4,000만 달러에 달할 전망입니다. 예측 기간 중 성장 요인으로는 재조합 백신 및 DNA 백신의 기술 발전, 반려견 예방 의료에 대한 관심 증가, 수의학 예방접종 프로그램 확대, 반려견 건강 관련 R&D 투자 증가, 예방접종 추적을 위한 디지털 툴 도입 등이 있습니다. 예측 기간의 주요 동향으로는 반려견 보호자의 백신 접종 인식 증가, 반려견용 다가 백신 개발, 예방 수의학의 보급 확대, 강아지 및 성견용 백신 프로그램 확대, 종합적인 예방접종 서비스를 제공하는 동물병원 증가 등을 들 수 있습니다.

인수공통전염병의 확산은 향후 수년간개 백신 시장의 성장을 가속할 것으로 예측됩니다. 인수공통전염병(Zoonoses)은 동물과 사람 사이에 자연적으로 전파될 수 있는 감염병을 말합니다. 야생동물 서식지에 대한 인간 활동의 확대로 동물과의 접촉 기회가 증가하고 질병 전파 위험이 높아진 것이 인수공통전염병 발생률 상승의 요인으로 작용하고 있습니다. 개 백신은 개에서 사람으로 전염되는 인수공통전염병의 확산을 방지하는 데 중요한 역할을 하며, 이러한 전염병을 통제하고 관리하는 광범위한 공중보건 정책을 지원하고 있습니다. 예를 들어 미국에 본사를 둔 독립적이고 비당파적인 싱크탱크이자 출판사인 외교문제협의회(CFR)에 따르면 2023년 2월 현재 새로 발견되는 전염병 또는 신흥 전염병(EIDs)의 최대 75%, 알려진 전염병의 60%가 인수공통전염병에 기인한다고 합니다. 전 세계에서 인수공통전염병은 연간 270만 명의 사망과 25억 건의 질병을 유발하고 있습니다. 따라서 인수공통전염병 증가 추세는 개 백신 시장의 성장을 가속하고 있습니다.

개 백신 시장의 주요 기업은 차세대 재조합 백신, RNA 기반 백신과 같은 혁신적인 백신 기술 개발에 집중하여 반려동물의 면역 반응성, 안전성 및 예방 효과의 지속성을 향상시키기 위해 노력하고 있습니다. 차세대개 백신은 첨단 플랫폼을 사용하여 표적 면역을 자극하는 것을 목표로 하며, 재조합 백신은 특정 항원을 이용하여 부작용을 최소화하고 효능을 향상시키는 것을 목표로 하고 있습니다. 예를 들어 2024년 6월 미국 농무부(USDA)는 미국 동물용 의약품 기업 머크 앤 컴퍼니(Merck & Company)의 MSD 동물 건강(MSD Animal Health)의 개용 차세대 RNA 입자 백신 '노비백 NXT개 인플루엔자 바이러스(CIV)'를 승인했습니다. 이는 신속한 면역 발현과 유행하는 바이러스 균주에 대한 강화된 방어력을 제공함으로써개 인플루엔자 예방에 있으며, 큰 진전을 의미합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Dog vaccines constitute a series of administered injections, commencing during the puppy stage and extending into adulthood. These vaccines aim to introduce small amounts of a virus particle to trigger an immune response in the dog's body. This proactive measure enables the dog to mount an immune defense in the event of exposure to bacteria or viruses, thereby preventing illness.

Key categories of dog vaccines encompass attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines involve creating a vaccine by reducing the virulence of a pathogen while maintaining its viability. Administration methods include subcutaneous, intramuscular, and intranasal routes, catering to dogs below 6 months and those above 6 months.

Tariffs have influenced the dog vaccines market by increasing import costs for raw materials, specialized vaccine formulations, and high-tech delivery systems, particularly impacting North America and Europe, where demand for advanced canine vaccines is high. Attenuated live, recombinant, and DNA vaccines segments are the most affected. However, tariffs are encouraging local manufacturing and innovation in cost-effective vaccine production, supporting regional supply resilience.

The dog vaccines market research report is one of a series of new reports from The Business Research Company that provides dog vaccines market statistics, including dog vaccines industry global market size, regional shares, competitors with a dog vaccines market share, detailed dog vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the dog vaccines industry. This dog vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dog vaccines market size has grown strongly in recent years. It will grow from $3.8 billion in 2025 to $4.07 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rise in dog population globally, increasing awareness of canine diseases, introduction of novel vaccine types, growth of veterinary healthcare infrastructure, rising prevalence of infectious canine diseases.

The dog vaccines market size is expected to see strong growth in the next few years. It will grow to $5.44 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advancements in recombinant and dna vaccines, increasing focus on canine preventive healthcare, expansion of veterinary immunization programs, rising investments in canine health r&d, adoption of digital tools for vaccination tracking. Major trends in the forecast period include increasing vaccination awareness among dog owners, development of multivalent vaccines for canines, rising adoption of preventive veterinary care, expansion of pediatric and adult canine vaccine programs, growth in veterinary clinics offering comprehensive immunization services.

The increasing prevalence of zoonotic diseases is expected to drive the growth of the dog vaccines market in the coming years. Zoonotic diseases, also called zoonoses, are infectious diseases that can be naturally transmitted between animals and humans. The incidence of zoonotic diseases is rising due to human population expansion into wildlife habitats, which increases contact with animals and the risk of disease transmission. Dog vaccines play a vital role in preventing the spread of zoonotic diseases from dogs to humans and support broader public health initiatives to control and manage these infections. For example, in February 2023, according to the Council on Foreign Relations (CFR), a US-based independent, nonpartisan think tank and publisher, up to 75% of newly discovered or emerging infectious diseases (EIDs) and 60% of recognized infectious diseases have zoonotic origins. Globally, zoonoses are responsible for 2.7 million human deaths and 2.5 billion disease episodes in people each year. Therefore, the rising prevalence of zoonotic diseases is propelling the growth of the dog vaccines market.

Leading players in the dog vaccines market are concentrating on developing innovative vaccine technologies, such as next-generation recombinant and RNA-based vaccines, to enhance immune response, safety, and duration of protection in companion animals. Next-generation canine vaccines aim to stimulate targeted immunity using advanced platforms, while recombinant vaccines utilize specific antigens to minimize adverse reactions and improve efficacy. For instance, in June 2024, according to Merck & Co. Inc.'s MSD Animal Health, a US-based animal health company, the United States Department of Agriculture (USDA) approved Nobivac NXT Canine Influenza Virus (CIV), a next-generation RNA-particle vaccine for dogs, representing a major advancement in canine influenza prevention by providing rapid immunity onset and enhanced protection against circulating virus strains.

In September 2024, Boehringer Ingelheim, a Germany-based company active in both human and animal health sectors, acquired Saiba Animal Health AG for an undisclosed amount. This acquisition strengthens Boehringer Ingelheim's research and development capabilities in the animal health sector, particularly in innovative therapeutic vaccines for pets, targeting chronic conditions such as allergies, inflammation, and pain. Saiba Animal Health AG, a Switzerland-based company, provides dog vaccines.

Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S.A.

Asia-Pacific was the largest region in the dog vaccines market in 2025. The regions covered in the dog vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dog vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The dog vaccines market consists of sales of vaccines for dogs including core dog vaccines, and non-core dog vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dog Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses dog vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dog vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dog vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; DNA Vaccines; Recombinant Vaccines
• 2) By Route Of Administration: Subcutaneous; Intramuscular; Intranasal
• 3) By Application: Below 6 Months; Above 6 Months
• Subsegments:
• 1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine; Canine Distemper Vaccine; Canine Adenovirus Vaccine
• 2) By Conjugate Vaccines: Canine Leptospira Vaccine; Canine Bordetella Vaccine
• 3) By Inactivated Vaccines: Canine Parvovirus Vaccine; Canine Influenza Vaccine
• 4) By Subunit Vaccines: Canine Lyme Disease Vaccine; Canine Parainfluenza Vaccine
• 5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
• 6) By DNA Vaccines: Canine Melanoma Vaccine
• 7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine; Canine Bordetella Recombinant Vaccine
• Companies Mentioned: Vetoquinol S.A.; Boehringer Ingelheim GmbH; Ceva Sante Animale; Heska Corporation; Merck & Co. Inc.; Virbac Animal Health Pvt. Ltd.; Elanco Animal Health Incorporated; Zoetis Inc.; CZ Vaccines; Indian Immunologicals Ltd.; Meiji Holdings Co. Ltd.; Bioveta A.S.; Phibro Animal Health Corporation; Hester Biosciences Limited; Dechra Pharmaceuticals PLC; Norbrook Inc.; Biogenesis Bago SA; Vaxxinova India Private Limited; Bimeda Animal Health Ltd.; Lohmann Animal Health GmbH; Biovac Ltd.; Zenex Animal Health India Pvt. Ltd.; Instituto Rosenbusch S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Dog Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Dog Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Dog Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Dog Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Vaccination Awareness Among Dog Owners
  • 4.2.2 Development Of Multivalent Vaccines For Canines
  • 4.2.3 Rising Adoption Of Preventive Veterinary Care
  • 4.2.4 Expansion Of Pediatric And Adult Canine Vaccine Programs
  • 4.2.5 Growth In Veterinary Clinics Offering Comprehensive Immunization Services

5. Dog Vaccines Market Analysis Of End Use Industries

• 5.1 Veterinary Clinics
• 5.2 Veterinary Hospitals
• 5.3 Dog Breeders
• 5.4 Pet Care Centers
• 5.5 Animal Shelters

6. Dog Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Dog Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Dog Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Dog Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Dog Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Dog Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Dog Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Dog Vaccines Market Segmentation

• 9.1. Global Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
• 9.2. Global Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Subcutaneous, Intramuscular, Intranasal
• 9.3. Global Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Below 6 Months, Above 6 Months
• 9.4. Global Dog Vaccines Market, Sub-Segmentation Of Attenuated Live Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
• 9.5. Global Dog Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Leptospira Vaccine, Canine Bordetella Vaccine
• 9.6. Global Dog Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Parvovirus Vaccine, Canine Influenza Vaccine
• 9.7. Global Dog Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
• 9.8. Global Dog Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Leptospirosis Toxoid Vaccine
• 9.9. Global Dog Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Melanoma Vaccine
• 9.10. Global Dog Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine

10. Dog Vaccines Market Regional And Country Analysis

• 10.1. Global Dog Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Dog Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Dog Vaccines Market

• 11.1. Asia-Pacific Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Dog Vaccines Market

• 12.1. China Dog Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Dog Vaccines Market

• 13.1. India Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Dog Vaccines Market

• 14.1. Japan Dog Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Dog Vaccines Market

• 15.1. Australia Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Dog Vaccines Market

• 16.1. Indonesia Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Dog Vaccines Market

• 17.1. South Korea Dog Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Dog Vaccines Market

• 18.1. Taiwan Dog Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Dog Vaccines Market

• 19.1. South East Asia Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Dog Vaccines Market

• 20.1. Western Europe Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Dog Vaccines Market

• 21.1. UK Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Dog Vaccines Market

• 22.1. Germany Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Dog Vaccines Market

• 23.1. France Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Dog Vaccines Market

• 24.1. Italy Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Dog Vaccines Market

• 25.1. Spain Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Dog Vaccines Market

• 26.1. Eastern Europe Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Dog Vaccines Market

• 27.1. Russia Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Dog Vaccines Market

• 28.1. North America Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Dog Vaccines Market

• 29.1. USA Dog Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Dog Vaccines Market

• 30.1. Canada Dog Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Dog Vaccines Market

• 31.1. South America Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Dog Vaccines Market

• 32.1. Brazil Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Dog Vaccines Market

• 33.1. Middle East Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Dog Vaccines Market

• 34.1. Africa Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Dog Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Dog Vaccines Market Regulatory and Investment Landscape

36. Dog Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Dog Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Dog Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Dog Vaccines Market Company Profiles
  • 36.3.1. Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Dog Vaccines Market Other Major And Innovative Companies

• Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH

38. Global Dog Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Dog Vaccines Market

40. Dog Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Dog Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Dog Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Dog Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer